GlassScriptPhysician profile
Sachin Patel
NPI 1821388539
$5,078.11
in general payments reported to CMS, 2019-2025
26 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $188 · 2021: $1,704 · 2022: $2,137 · 2023: $196 · 2024: $301 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $2,400.00 | 2021-2022 | |
| Stryker Corporation | $1,047.91 | 2019-2024 | Variax, Inbone |
| Paratek Pharmaceuticals, INC. | $246.30 | 2021-2024 | Nuzyra |
| Integra Lifesciences Corporation | $191.51 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Musculoskeletal Transplant Foundation INC. | $177.59 | 2020-2021 | |
| Smith+Nephew, INC. | $149.77 | 2024 | Grafix Pl, Stravix Pl, Oasis |
| Orthofix Medical, INC. | $130.89 | 2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $111.90 | 2021 | |
| Comsort, INC | $100.00 | 2019 | |
| Bioventus LLC | $67.73 | 2019-2021 | |
| Convatec INC. | $51.51 | 2019-2023 | |
| Acumed LLC | $46.11 | 2022 | |
| Nevro Corp. | $42.86 | 2021-2022 | |
| Stimwave Technologies Incorporated | $40.55 | 2019 | |
| Paragon 28, INC. | $40.13 | 2023 | Gorilla |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $38.67 | 2022 | |
| Organogenesis INC. | $34.05 | 2020-2021 | |
| Wright Medical Technology, INC. | $29.12 | 2019 | |
| Sebela Pharmaceuticals INC. | $25.82 | 2022-2023 | Naftin |
| Abbott Laboratories | $24.22 | 2023 | Proclaim |
| Si-Bone, INC. | $23.43 | 2021 | |
| Grt US Holding, INC. | $13.60 | 2022 | |
| Merck Sharp & Dohme LLC | $13.00 | 2019 | |
| Sandoz INC. | $12.59 | 2019 | |
| Axogen | $10.85 | 2019 | |
| Glenmark Therapeutics INC. | $8.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sachin Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.